2024 Midwest Radiation Oncology Symposium (Attendee Information)
Welcome! Thank you for joining us.
This symposium aims to bring together the brilliant minds of physicians and physicists, fostering an interdisciplinary dialogue that explores the immense potential of AI in revolutionizing radiation oncology.
Our primary objectives are to delve into the latest advancements, share groundbreaking research, and discuss collaborative strategies for integrating AI seamlessly into clinical practices.
This symposium is a unique opportunity to explore the intersection of medicine and technology.
Symposium Dates
|
|
Friday-Saturday, Aug. 23-24 Friday: 7:00 a.m. – 4:20 p.m. US CDT |
Attendance Options
 |
In-Person Complimentary parking for campus visitors is available in Lot 50 — top level only (45th and Emile). |
 |
Live Stream Via Zoom – Check your email for instructions on how to join the live stream. |
Symposium Objectives
At the conclusion of this activity, the participants should be better able to:
- Explore the transformative role of technology in modern oncology, encompassing Artificial Intelligence integration in radiotherapy practices, advancements in medical image analysis, and its impact on personalized treatment approaches.
- Investigate innovative radiation techniques such as proton FLASH and stereotactic body radiotherapy (SBRT), focusing on mechanisms of action and their potential applications across different cancer types.
- Examine strategies for effective patient communication and education, including eLearning, simulation-based training, and the role of global health rotations in residency programs for fostering cultural competency and enhancing patient care.
- Evaluate the evolving landscape of cancer diagnosis, with a spotlight on the application of AI in brain tumor detection and characterization.
- Discuss contemporary approaches to the management of various malignancies, including early-stage non-small cell lung cancer, renal masses, and prostate cancer risk stratification through radiomics.
- Explore the multidisciplinary nature of cancer treatment, with insights into the roles and responsibilities of healthcare professionals in delivering comprehensive care at community cancer centers.
- Identify current and emerging surgical and radiotherapy strategies for soft tissue sarcoma management.
- Review the latest advancements in the treatment of hepatocellular carcinoma, including Y90 radioembolization, SBRT, and immunotherapy.
Target Audience
This accredited continuing education activity is designed for medical physicists, radiation therapists, dosimetrists, nurses, physicians, fellows, residents, and students.
Symposium Agenda
In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The University of Nebraska Medical Center designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The University of Nebraska Medical Center designates this activity for 13.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Others
Commission on Accreditation of Medical Physics Education Program (CAMPEP), American Society of Radiologic Technologists (ASRT), and Medical Dosimetrist Certification Board (MDCB) credits will also be available.
Read the UNMC CCE Disclosure Declaration Policy
Disclosures
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.
FACULTY
The following have disclosed relevant financial relationships:
- Clifton David Fuller, MD, PhD
Advisory Service/Honoraria/Travel: Varian Medical Systems, Inc. (A Siemens Healthineers Company)
Grants/Honoraria/Travel: Elekta
Honoraria/Travel: Koninklijke Philips N.V.
Patents/Royalties: Kallisio, Inc. - Megan Hyun, PhD, DABR
Speaker's Bureau: Varian Medical Systems, Inc. (A Siemens Healthineers Company) - Harshraj Leuva, MBBS
Advisory Board: Astellas Pharma Inc., Seagen Inc. - Joseph McBride, MD
Consultant: Integer Holdings Corporation
- Sean McGarry, MD
Medical Board of Trustees: Musculoskeletal Transplant Foundation (MTF) - Jeffery Ryckman, MD
Advisory Board: NewLeaf.ai, Inc. - Nicole Shonka, MD
Consultant: GT Medical Technologies, Inc.
- Chi (Kevin) Zhang, MD, PhD*
Grant: AstraZeneca, BioMimetix Pharma
Co-founder: ZCure LLC - Dandan Zheng, PhD, DABR
Research Agreement: Varian Medical Systems, Inc. (A Siemens Healthineers Company)
The following faculty members have nothing to disclose:
- Omar K.M. Abughanimeh, MBBS
- Michele Aizenberg, MD, FAANS, FACS
- Hana Baroudi, MS
- David Berkheim, MD
- Lisa Chaiken, MD
- Serdar Charyyev, PhD
- Jie Chen, MD, PhD
- Yabo Fu, PhD
- Kyle J. Gallagher, PhD, DABR
- Hao Gao, PhD
- Linda M. Huynh, PhD, MSc
- Qateeb Khan, MD
- Mridula Krishnan, MBBS
- Chi Lin, MD, PhD*
- Ruirui Liu, PhD, CHP
- Sara Abou Naej, MS
- Kyuhak Oh, PhD
- Jared P. Schober, MD
- Diane Schott, PhD, DABR
- Andrew Wahl, MD
- Shuo Wang, PhD
- Xiaofeng Yang, PhD, DABR
- Xiandong Zhao, PhD
- Weining (Ken) Zhen, MD, FACR, FASTRO
- Sumin Zhou, PhD
PLANNING COMMITTEE
The following planning committee members have nothing to disclose:
- Michael Baine, MD, PhD
- Dinah Clark
- Valeta Creason-Wahl, HMCC
- Charles Enke, MD, FACR, FASTRO
- Tori Greenlee
- Julie Huglin
- Heidi Keeler, PhD, MSN/MBA, RN
- Yu Lei, PhD
- Renee Paulin, MSN, RN, CWOCN
- Brenda Ram, CMP, CHCP
- Hongmei Ren, BSN, RN
- Ann L. Yager, MHA, BS, RT, (R) (T), CT
*Faculty and planning committee member
The following materials (in PDF) are available for download until Sept. 13, 2024. No part of these materials may be reproduced without prior written permission.
Friday, Aug. 23
DEPARTMENT CHAIR WELCOME AND INTRODUCTORY REMARKS
- Unlocking Innovations in Cancer Care - AI in Radiation Oncology
Charles A. Enke, MD, FASTRO, FACR
KEYNOTE PRESENTATION
- Advances in AI-Based Prediction Models for Radiation Oncology
Clifton David Fuller, MD, PhD
SESSION 1: GENITOURINARY CANCER I
- Assessing Cancer Treatment Efficacy: The Past, the Present, and the Future!
Harshraj Leuva, MBBS - Radiomics: The Intersection of Artificial Intelligence and Prostate Cancer Risk Stratification
Linda M. Huynh, PhD, MSc
SESSION 2: GENITOURINARY CANCER II
- The Use of Nuclear Imaging in the Workup and Management of a Renal Mass
Jared P. Schober, MD - Prostate Cancer Treatment and PSMA PET Imaging: Patterns of Care at June E. Nylen Cancer Center
Lisa Chaiken, MD
SESSION 3: SARCOMA
- Current and Novel Radiotherapy Approaches to Soft Tissue Sarcoma
Andrew Wahl, MD - Surgical Approaches to the Management of Soft Tissue Sarcomas
Sean McGarry, MD
SESSION 4: BRAIN TUMOR
- Applications of Artificial Intelligence in Brain Tumor Diagnosis
Jie Chen, MD, PhD - Repurposing FDA-Approved Drugs for Glioma Therapy
Nicole Shonka, MD
- Accurate Prediction of Individual Brain Function Maps From Structural Imaging Utilizing Deep Learning
Michele Aizenberg, MD, FAANS, FACS - Radiomic-Assisted Imaging Diagnosis of Brain Metastasis: How to Exceed Human Eye Limitations
Chi (Kevin) Zhang, MD, PhD
SESSION 5: HEPATOCELLULAR CARCINOMA
- Targeting the Core: Yttrium-90 Radioembolization in Hepatocellular Carcinoma Management
Joseph McBride, MD - Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma
Chi Lin, MD, PhD
- Optimizing Treatment Strategies: Immunotherapy in Combination with Local Therapy for Hepatocellular Carcinoma
Mridula Krishnan, MBBS
Saturday, Aug. 24
KEYNOTE PRESENTATION
- Leveraging AI in Precision Radiotherapy: Advancements in Medical Image Analysis
Xiaofeng Yang, PhD, DABR
SESSION 6: AI IN RADIOTHERAPY APPLICATION I
- AI-Powered Precision: Real-Time Markerless Tracking in X-Ray Imaging
Yabo Fu, PhD - Use of AI to Improve Access to Radiotherapy in Low and Middle-Income Countries (LMICs)
Hana Baroudi, MS
SESSION 7: FLASH RADIOTHERAPY
- Normal Tissue Sparing via Proton FLASH, Spatially Fractionated Radiation Therapy (SFRT) and Beyond
Hao Gao, PhD - G4NDA-Based Radiochemical Monte Carlo Model to Investigate DNA Damage and FLASH Mechanism
Xiandong Zhao, PhD
SESSION 8: INNOVATION IN MEDICAL PHYSICS EDUCATION
- An International Exchange: Bi-Directional Global Health Rotation for Residency Training Programs in a High-Income Country and a Low- and Middle-Income Country
Sara Abou Naej, MS - Innovative Patient Communication Training Using eLearning and Simulation
Megan Hyun, PhD, DABR
SESSION 9: NON-SMALL CELL LUNG CANCER
- Debunking Myths: Is More Resection Always Better in Stage I Lung Cancer?
David Berkheim, MD - SBRT in Centrally-Located Stage I Lung Cancer: Navigating Treatment Challenges
Qateeb Khan, MD - Expanding Treatment Horizons: The Role of Immunotherapy in Stage I Lung Cancer
Omar K. M. Abughanimeh, MBBS - Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617
Jeffrey Ryckman, MD
SESSION 10: AI IN RADIOTHERAPY APPLICATION II
- Adaptive Radiotherapy and the Role of Artificial Intelligence
Dandan Zheng, PhD, DABR - Towards Developing an AI-Powered Digital Twin Modeling Framework for Personalized Radiotherapy
Ruirui Liu, PhD, CHP - Advancements of Artificial Intelligence in Proton Therapy
Serdar Charyyev, PhD
Requirements for Successful Completion
In order to receive continuing education credits, you must:
- Check in and attend the live activity.
- In-person: Check in at the registration desk.
- Live stream: Type in your first and last name in the Zoom chat.
- Complete the online evaluation via the UNMC MyCCE portal.
- On your dashboard, click Evaluate an Activity.
- Live Stream attendees, enter Activity Code:
62023 – Friday, August 23 only
62025 – Saturday, August 24 only
62027 – Full Symposium - In Person attendees, enter Activity Code:
62022 – Friday, August 23 only
62024 – Saturday, August 24 only
62026 – Full Symposium
You have until Sept. 13, 2024, to claim credit for this activity. You will need to complete the evaluation and attest to the time you spent participating in the activity. Your certificate will be saved in your UNMC MyCCE account under Certificates & Transcripts.
Need help managing your MyCCE account? Find answers to commonly asked questions about signing in to the portal, completing the online evaluation, retrieving your certificate, and more. Go to Manage MyCCE Account
Symposium Director
Professor and Vice Chair of Research, Department of Radiation Oncology, UNMC
Questions?
Director, Educational Programs
UNMC Center for Continuing Education
